Sign in

CIK 0000875320

  • Large accelerated filer

VERTEX PHARMACEUTICALS INC / MA

Sign in to watch
Ticker
VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
043039129
Phone
+1 617-341-6393
Business address
50 NORTHERN AVENUE, BOSTON, MA, 02210
  1. 4 Grant or award Director acquired 922 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Grant or award EVP, Chief Technical Ops. Off. acquired 14,112 shares (grant or award)
  4. 4 Grant or award Director acquired 1,001 shares (grant or award)
  5. 4 Grant or award Director acquired 501 shares (grant or award)
  6. 4 Derivatives Options or other derivatives
  7. 4 Grant or award Director acquired 1,001 shares (grant or award)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Grant or award Director acquired 1,001 shares (grant or award)
  12. 4 Planned sale Director sold 467 shares at $402.95 ($188,178)
  13. 4 Derivatives Options or other derivatives
  14. 4 Planned sale SVP & Chief Accounting Officer sold 240 shares at $419.00 ($100,560)
  15. 4 Shares withheld for taxes EVP & Chief Financial Officer gave up 3,309 shares (to pay taxes)
  16. 4 Planned sale EVP, Chief Reg. & Quality Off. sold 354 shares at $425.70 ($150,698)
  17. 4 Planned sale EVP Chief Patient & Ext Af Off sold 3,004 shares at $425.70 ($1,278,803)
  18. 4 Shares withheld for taxes CEO & President gave up 9,386 shares (to pay taxes)
  19. 4 Shares withheld for taxes EVP and CMO gave up 3,309 shares (to pay taxes)
  20. 4 Planned sale EVP, Chief Technical Ops. Off. sold 883 shares at $425.70 ($375,893)

Page 13 of 129 · 2,568 filings